• D-Luciferin: Unraveling Bioluminescence for Advanced Oncolog

  2026-06-02

  Explore how D-Luciferin, a premier firefly luciferase substrate, empowers next-generation bioluminescence imaging in oncology. This in-depth analysis highlights mechanistic insights, practical assay optimization, and new translational opportunities beyond conventional workflows.

• Lactylation-Driven KRT19 Fuels NSCLC by Suppressing Senescen

  2026-06-02

  Zhang et al. demonstrate that lactate-driven histone lactylation at H3K18 promotes KRT19 expression, which in turn suppresses cellular senescence and accelerates non-small cell lung cancer (NSCLC) progression. Their mechanistic findings highlight KRT19 as a mediator of immune evasion and a promising therapeutic target for combination strategies in NSCLC.

• Applied Workflows with Recombinant Human Growth Hormone (GH)

  2026-06-01

  Leverage APExBIO’s Recombinant Human Growth Hormone (GH) for robust cell proliferation and IGF-1 pathway assays. Unlock reproducible chondrocyte differentiation models and actionable troubleshooting strategies by integrating the latest mechanistic insights on the IGFBP2–THBS1 axis.

• Bazedoxifene: Translating ER Modulation into Osteoporosis Re

  2026-06-01

  This thought-leadership article unpacks the mechanistic and translational significance of Bazedoxifene, a third-generation selective estrogen receptor modulator (SERM), for osteoporosis research and beyond. Integrating biological rationale, key experimental findings, and competitive context, it offers actionable guidance for translational scientists seeking to leverage Bazedoxifene for bone mineral density enhancement, estrogen pathway interrogation, and advanced workflow reliability. Drawing on the latest peer-reviewed evidence and APExBIO’s robust laboratory product, this piece provides a strategic outlook on future research directions.

• ABT-888 (Veliparib): Applied PARP Inhibition for Cancer Rese

  2026-05-31

  ABT-888 (Veliparib) empowers researchers to dissect DNA repair inhibition and sensitize MSI tumor models to chemotherapy and radiation. Learn how optimized workflows, troubleshooting, and recent insights translate into actionable cancer biology assays with this potent PARP1/2 inhibitor from APExBIO.

• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-05-30

  Schwartz’s dissertation establishes a framework distinguishing proliferative arrest from cell death in in vitro cancer drug testing. This approach enhances the accuracy of preclinical evaluation, informing translational research and assay design.

• Pharmacokinetics of Vernakalant Hydrochloride: CYP2D6 and AF

  2026-05-29

  This article dissects the pharmacokinetic profile of Vernakalant Hydrochloride (RSD1235) for rapid atrial fibrillation conversion, focusing on the impact of CYP2D6 metabolism. The reference study demonstrates that CYP2D6 phenotype has minimal influence on acute intravenous dosing, supporting streamlined clinical and translational protocols.

• MLKL Polymerization Triggers Lysosomal Permeabilization in N

  2026-05-29

  This study reveals that polymerized MLKL directly induces lysosomal membrane permeabilization (LMP), leading to cathepsin B (CTSB) release and subsequent necroptotic cell death. The work clarifies the sequence of membrane events during necroptosis and highlights CTSB as a critical effector, opening new avenues for targeted intervention in inflammation and cell death research.

• Stress Fiber Anisotropy Regulates Force-Driven Chromatin and

  2026-05-28

  Wei et al. (2020) demonstrate that the orientation and integrity of actin stress fibers govern how local mechanical forces stretch chromatin and regulate gene transcription in living cells. Their work employs advanced 3D magnetic twisting cytometry, providing evidence that anisotropic cytoskeletal organization is central to force-mode dependent gene responses.

• Cefoperazone Sodium Salt: Advanced Insights for Cutting-Edge

  2026-05-28

  Explore the scientific foundations and nuanced applications of Cefoperazone sodium salt in modern antibacterial research. This article offers advanced analysis, unique practical guidance, and new perspectives for researchers seeking robust, β-lactamase-stable solutions.

• FBXW7 Regulates SPT6-ΔNp63 Axis to Suppress Esophageal Cance

  2026-05-27

  This study reveals that FBXW7, a substrate receptor of Cullin-RING ligase-1 (CRL1), targets the SPT6-ΔNp63 axis for degradation, thereby inhibiting esophageal squamous cell carcinoma (ESCC) induced by chemical carcinogenesis. The findings define a novel mechanistic pathway with implications for therapeutic targeting and the design of research tools probing ubiquitin-proteasome and neddylation pathways.

• Bifendate (DDB): Integrative Mechanisms and Translational In

  2026-05-27

  Explore how Bifendate (DDB) advances hepatoprotection and lipid metabolism regulation while revealing new translational strategies. This in-depth analysis uncovers mechanistic nuances, protocol guidance, and key findings that set Bifendate apart in liver disease research.

• Chemical Genetics Dissection of Jasmonate Signaling via Best

  2026-05-26

  This study demonstrates how the aminopeptidase inhibitor bestatin can be leveraged as a chemical genetics tool to dissect the jasmonate signaling pathway in Arabidopsis. The findings establish bestatin’s specificity for jasmonate-responsive gene activation and reveal new genetic loci involved in plant defense and development, offering a model for pathway dissection using small molecules.

• D-Luciferin Sodium Salt: Precision Tools for CAR-Macrophage

  2026-05-26

  Explore how D-Luciferin sodium salt empowers advanced bioluminescent imaging of engineered immune cells. This article uniquely bridges precise firefly luciferase substrate use with cutting-edge CAR-macrophage assays, offering actionable insights for oncology and immunotherapy research.

• L-Alanyl-L-Glutamine (B8228): Protocols for GI Barrier Suppo

  2026-05-26

  L-Alanyl-L-Glutamine (B8228) addresses challenges in maintaining intestinal barrier integrity, supporting antioxidant systems, and reducing inflammation in gastrointestinal research models. It is best suited for protocols requiring a stable, water-soluble glutamine dipeptide supplement where solubility, purity, and barrier function enhancement are critical. It should not be used in workflows requiring solubility in DMSO or ethanol, or where long-term solution stability is needed.

451 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page